Showing results (131-140 of 550) with videos related to
Sort By:
Pageof 55
Biochemical and Biophysical Research Communications|May 16, 1984
Loss of epidermal growth factor receptor on the renal neoplasm induced in vivo with Xenotropic pseudotype Kirsten murine sarcoma virusT Usui, N Moriyama, T Ishibe, et al.British Journal of Urology|March 1, 1994
Association between patient characteristics and treatment history, and toxicity associated with methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced urothelial cancerM Igawa, H Kadena, M Ueda, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatinM Igawa, T Ohkuchi, M Ueda, et al.Journal of Medicinal Chemistry|April 26, 2000
Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analoguesH Wang, T Usui, H Osada, et al.The Journal of Urology|February 15, 2001
Evaluation of antibody class in response to endoscopic subureteral collagen injection in patients with vesicoureteral refluxK Inoue, T Nakamoto, A Usui, et al.Archives of Biochemistry and Biophysics|November 30, 2000
Chemoenzymatic synthesis of glycopolypeptides carrying alpha-Neu5Ac-(2-->3)-beta-D-Gal-(1-->3)-alpha-D-GalNAc, beta-D-Gal-(1-->3)-alpha-D-GalNAc, and related compounds and analysis of their specific interactions with lectinsX Zeng, Y Nakaaki, T Murata, et al.Carbohydrate Research|December 16, 1993
Transglycosylation reaction of maltotriose-forming amylase from Streptomyces griseusT Usui, T Murata, Y Yabuuchi, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimenM Igawa, H Kadena, M Ueda, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|September 1, 1994
M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by rhG-CSFM Ueda, M Igawa, H Kadena, et al.Chemical & Pharmaceutical Bulletin|February 20, 1998
Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonistsT Kakigami, T Usui, K Tsukamoto, et al.Pageof 55